Verici Dx plc (LON:VRCI – Get Free Report)’s stock price dropped 18.2% during mid-day trading on Thursday . The company traded as low as GBX 2.25 ($0.03) and last traded at GBX 2.25 ($0.03). Approximately 624,617 shares changed hands during trading, a decline of 29% from the average daily volume of 884,824 shares. The stock had previously closed at GBX 2.75 ($0.04).
Verici Dx Stock Down 20.7 %
The company has a market capitalization of £6.62 million, a PE ratio of -1.26 and a beta of 1.59. The company’s fifty day moving average is GBX 3.24 and its 200-day moving average is GBX 3.90. The company has a debt-to-equity ratio of 4.64, a quick ratio of 8.49 and a current ratio of 4.54.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- 3 Healthcare Dividend Stocks to Buy
- Energy Transfer: Powering Data With Dividends and Diversification
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Qualcomm Stock Is Coiling for a Breakout
- Following Congress Stock Trades
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
